Active, Not Recruiting
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
NCT04490915
- Conditions
- Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
- Locations
-
- Neurocrine Clinical Site Los Angeles, California, United States
- Neurocrine Clinical Site San Diego, California, United States
- Neurocrine Clinical Site San Francisco, California, United States
- Neurocrine Clinical Site Aurora, Colorado, United States